Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Learn which indices traders watch most closely and why. This quick primer covers the benchmarks that shape trading strategies and risk assessment.
26,463 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Retirees chasing large payouts face a hidden danger: high yields often come from falling stock prices rather than str...
Christopher Nolan delivers a blockbuster opening for The Odyssey, outperforming Oppenheimer and marking his best star...
California regulators said Tesla will not face a 30-day suspension after dropping marketing terms tied to its driver-...
Travel finally bounced back, and hotel owners like Host Hotels faced a new set of challenges and opportunities. This ...
A practical look at Farmland Partners (FPI) earnings and what they mean for investors. We break down the numbers, tre...
As butterfly (BFLY) prepares for 2025 earnings, investors want clarity on growth, margins, and cash runway. This arti...
The Global X Robotics & Artificial Intelligence ETF (BOTZ) is quietly tilting toward AI chips, with NVIDIA among its ...
Could tesla stock going $1,000? happen? This article weighs the drivers, risks, and a solid plan for investors consid...
A new ActivTrak analysis finds AI isn’t reducing workloads employees, instead boosting routine tasks and trimming dee...
A Goldman Sachs survey finds most small businesses are using AI with optimism about revenue gains, but only a minorit...
Looking to ride a big move in a small-cap space? Learn how to spot a small-cap growth stock before it hits its next e...